Beech Hill Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-53,975
Closed -$4.83M 78
2018
Q3
$4.83M Buy
53,975
+11,925
+28% +$1.05M 2.5% 15
2018
Q2
$3.34M Buy
42,050
+11,256
+37% +$935K 1.87% 27
2018
Q1
$2.75M Buy
30,794
+3,450
+13% +$331K 1.45% 34
2017
Q4
$2.85M Buy
27,344
+24,005
+719% +$2.71M 1.41% 34
2017
Q3
$487K Buy
+3,339
New +$455K 0.26% 56
2015
Q4
Sell
-3,594
Closed -$389K 107
2015
Q3
$389K Buy
+3,594
New +$446K 0.25% 64
2015
Q2
Sell
-5,300
Closed -$611K 138
2015
Q1
$611K Sell
5,300
-250
-5% -$29.9K 0.29% 61
2014
Q4
$621K Buy
5,550
+1,950
+54% +$206K 0.31% 58
2014
Q3
$341K Buy
+3,600
New +$325K 0.16% 96
2014
Q1
Sell
-6,130
Closed -$518K 155
2013
Q4
$518K Sell
6,130
-362
-6% -$28.6K 0.26% 73
2013
Q3
$500K Buy
6,492
+1,842
+40% +$129K 0.27% 68
2013
Q2
$272K Buy
+4,650
New +$280K 0.15% 101

Other funds holding CELG

Beech Hill Advisors's CELG Position: Q4 2018 in Review

Beech Hill Advisors sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 53,975 shares — an estimated $4.83M sold.

Beech Hill Advisors first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $4.83M in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Beech Hill Advisors reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Beech Hill Advisors sold 53,975 Celgene Corp shares in Q4 2018, an estimated $4.83M.
  • Beech Hill Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
  • Beech Hill Advisors's Celgene Corp position peaked at $4.83M in Q3 2018.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Beech Hill Advisors's 13F filing for Q4 2018, filed 14 Jan 2019.